Cygnus Biosciences

Cygnus Biosciences was founded in 2015, is headquartered in Beijing, China, and has 1 recorded funding round.

Headquarters
Beijing
Founded
2015
Business Model
B2B
Last Round
Venture RoundOct 2025
Rounds
1

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Cygnus Biosciences (赛纳生物) is a Chinese high-tech enterprise focused on gene sequencing technology research, development, and commercialization. The company has developed two proprietary core sequencing technologies — Fluorogenic sequencing chemistry and Error-Correction Code (ECC) sequencing — enabling high-accuracy, long-read sequencing with a data quality of up to Q40. Its S100 desktop sequencer and accompanying reagent kits serve life science research institutions and clinical genetic diagnostics labs, with applications in oncology, pathogen detection, reproductive health, and environmental safety.

Summary

Cygnus Biosciences is a Biotech company based in Beijing, China, founded in 2015. Its most recent funding was a Venture Round in Oct 2025. Investors include E-Town Capital.

Funding History

Venture RoundFunding RoundOct 2025

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cygnus Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/cygnus-biosciences"><img src="https://indexed.vc/api/badge/company/cygnus-biosciences" alt="Cygnus Biosciences on Indexed.vc" width="260" height="76" /></a>